- SynonymsN-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide-13C-D3 Potassium Salt
- Description
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide-13C-D3 Potassium Salt
Raltegravir 13C-D3 K salt is a fully characterized chemical compound used as a reference standard of API Raltegravir. The standard offered is compliant with regulatory guidelines. Raltegravir 13C-D3 K salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
2,2'-Azobis[2-methyl-propanimidamide] Dihydrochloride
M.F.
M.W. 198.27 2*36.46
CAT# AR-R10250
CAS# 2997-92-4